|
On the latest (and final) episode of This Week In Startups "The Next Unicorns" miniseries, Jason is joined by Sajith Wickramasekara, Co-Founder & CEO of Benchling.
Sajith Wickramasekara is increasing efficiency for scientists with a cloud-based platform, gives insights on recent life-science innovations, ethics of gene therapy & defining the line between quackery & brilliance –number 10 of 10-episode miniseries.
Favorite Moments 🔥:
1:40 What does Benchling do?
2:24 How did Sajith get into life science?
6:55 Benchling's value proposition for scientists
13:25 Why immunotherapy is the most exciting development in life science
19:00 3D Printing & harvesting organs in other species
20:50 Ethics of editing a human embryo
28:19 How did the scientific community respond to the embryo controversy
29:52 Breakthroughs in gene therapy
42:37 Upside & downside of genetically modified crops
47:54 What is the best approach for breakthroughs in life science?
Click below to listen to the full episode
|